Dysregulated Alternative Splicing in Breast Cancer Subtypes of RIF1 and Other Transcripts.

For LumB, HER2E, and basal cancers we observed no significant change in total RIF1 mRNA expression between tumour and matched normal samples separated ( Figure 2 A), while for LumA cancers we observed a marginally significant drop in expression, consistent with there being no significant change in RIF1 expression when considering all breast cancers combined ( Figure 1 C).

also in 26,082 other papers